Fulgent Genetics acquires Bako Diagnostics and StrataDx to expand AI pathology strategy

Fulgent Genetics acquires Bako Diagnostics and StrataDx to scale AI pathology, expand national reach, and advance precision medicine strategy. Read full analysis.